Quantitative determination of the MDR-related P-glycoprotein, pgp 170, by a rapid flow cytometric technique

Cytometry

Volumn 23, Issue 2, 1996, Pages 120-125

  Ferrand, Valérie L ^a   Montero Julian, Félix A ^b   Chauvet, Michèle M ^a   Hirn, Michel H ^b   Bourdeaux, Madeleine J ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Immunotech   (France)

Author keywords

K 562 lines; MRK 16; Multidrug resistance; Pgp 170; Quantitative flow cytometry

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TUMOR CELL LINE;

DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; P-GLYCOPROTEIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030021362     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960201)23:2<120::AID-CYTO5>3.0.CO;2-O     Document Type: Article

References (40)

1. Biedler JL, Riehm H: Cellular resistance to Actinomycin D in Chinese Hamster cells in vitro. Cross-resistance, radioautographic and cytogenetic studies. Cancer Res 30.1174-1184, 1970
2. Boscoboinik D, Debanne MT, Stafford AR, Jung CY, Gupta RS, Epands RM: Dimerization of the P glycoprotein in membranes. Biochim Biophys Acta 1027:225-228, 1990.
3. Bradley G, Juranka PF, Ling V: Mechanism of multidrug resistance Biochim Biophys Acta 948:87-128, 1988.
4. Broxterman H, Pinedo H, Kuiper CM, Van Der Hoeven JJM, De Lange P, Quak JJ, Scheper RJ, Keiser HG, Schuurhuis GJ, Lankelma J Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of multidrug resistance. Int J Cancer 43 340-343, 1989.
5. Charpin C, Vielh P, Duffaut F, Devictor B, Andrac L, Lavaut MN, Allasia C, Horschowski N, Piana L: Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: Correlation to messenger RNA expression and to immuno histochemical prognostic indicators. J Natl Cancer Inst 86:1539-1545, 1994.
6. Chin KV, Chaudan SS, Pastan I, Gottesman MM: Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells Cell Growth Differ 1:361-365, 1990.
7. Fogh J, Trempe G: New human tumor cells in vitro In: Human Tumor Cells in Vitro, Fogh J (ed). Plenum Press, New York, 1975, pp 115-119.
8. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci USA 4.265-269, 1987.
9. Gala J, McLachan M, Bell DR, Michaux JL, Ma DDF. Specificity and sensitivity of immunocytochemistry for detecting P-glycoprotein in haematological malignancies J Clin Pathol 47:340-343, 1994.
10. Gheuens EOE, Van Bockstaele DR, Van Derkeur M, Tanke HJ, Van Oosterom AT, De Bruijn, AE: Flow cytometry double labelling technique for screening of multidrug-resistancc. Cytometry 12.636-644, 1991
11. Goldstein LJ, Garski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pinker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM: Expression of multidrug resistance gene in human cancers J Natl Cancer Inst 81:116-124, 1989.
12. Gros P, Neriah YB, Croop JM. Housman DE: Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323 728-731, 1986
13. Haak HR, Van Seters AP, Moolenaar AJ, Fleurens GJ: Expression ot P-Glycoprotcin in relation to clinical manifestation, treatment and prognosis of adrenocortical cancer Eur J Cancer 29A-1036- 1038. 1993
14. Hait WN, Choudhury S, Srimatkandada S, Murren, JR Sensitivity of K 562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs. J Clin Invest 91-2207-2215, 1993
15. Hamada H, Tsuruo T. Functional role for the 170 to 180 kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83 7785-7789, 1986.
16. Hunter WM, Greenwood FC: Preparation of iodine-131 labelled hu man growth hormone of high specific activity Nature 194-495-496, 1962.
17. Juliano RL, Ling V: A surface glycoprotein modulating drug permcability in CHO cell mutants. Biochim Biophys Acta 405 152-162, 1976.
18. Krishan A, Saverteig A. Stein JH: Comparison of three commercially available antibodies for flow cyrometric monitoring of P giycoprotem in clinical leukemic cells. Cytometry 12:731-742, 1991
19. AD human ovarian carcinoma cells against a concentration gradient. Biochim Biophys Acta 1055:217-222, 1990
20. Leonce S, Pierre A, Anstett M, Perez V, Genton A, Bizzan JP, Arassi G: Effects of a new triazinoaminopipcridine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Biochem Pharmacol 44.1707-1715. 1992.
21. Ling V.: Does P-glycoprotein predict response to chemotherapy? J Natl Cancer Inst 81.84-85, 1989.
22. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia Chromosome. Blood 45:321-334, 1975.
23. MacRoberts JA, Toubaud MH The Madin Darly Canine Kidney (MDCK) cell line In: Funtionally Differentiated Cell lines. Alan R. Liss, New York, 1981, pp 117-139.
24. 1) gene expression in adult acute leukemia: Correlation with treatment outcome and in vitro drug sensitivity Blood 78.586-592, 1991.
25. 1 mRNA levels by polymerase chain reaction In. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells Roninson IB (ed). Plenum Press, New York, 1991, pp 319-333.
26. Pastan I, Gottesman MM: Multidrug resistance in human cancer. N Eng J Med 316.1388-1393, 1989.
27. Pereira E, Borrel MN, Fiallo M, Garnier-Suillerot A: Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K 562 cells Biochim Biophys Acta 1225:209-216, 1994
28. Pileri SA, Sabattini E, Falini B, Tazzari PL, Gherlinzoni F, Michieli MG, Damiani D, Zucchini L, Gobbi MP, Tsuruo T, Baccarani M: Immunohistological detection of the multidrug resistance transport protein GP170 in human normal tissues and malignant lymphomas Histopathology 19.131-140, 1991
29. Poncelet P, Carayon P: Cytofluorimetric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods 85.65-74, 1985.
30. Poncelet P, Lavabre-Bertrand T, Carayon P: Quantitative phenotypes of B chronic lymphocytic leukemia B cells established with monoclonal antibodies from the B cell protocol In. Leucocytes Typing II, Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds). Springer-Verlag, New York. 1986. pp 329-343.
31. Poncelet P, George F, Lavabre-Bertrand T: Immunological detection of membrane-bound antigens and receptors. In: Methods of Immunological Analysis. Masseyeff RF, Albert WH, Staines NA (eds). Verlagsgesellschaft, Weinheim, 1993, pp 388-417
32. Riordan JR, Ling V. Purification of P-glycoprotein from plasma membrane vesicles of CHO cell mutants with reduced colchicine permeability J Biol Chem 254:12701-12705, 1979.
33. 1 gene expression can precede gene amplification. Science 232:643-645, 1986
34. Tanako H, Kohno K, Matsuo K, Matsuda T, Kuwano M Topoisomerase-targeting anti-tumor agents and drug resistance Anticancer Drugs 3.323-330, 1992.
35. Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full length cDNA for the human mdr1 gene that confers resistance to colchicine, doxorubicin and vinblastine. Proc Natl Acad Sci USA 84:3004-3008, 1987.
36. Van Acker KL, Van Hove LM, Boogaerts MA: Evaluation of flow cytometry for multidrug resistance detection in low resistant K 562 cells using daunorubicin and monoclonal antibodies. Cytometry 14: 736-746, 1993
37. Warr JR, Artderson M, Fergusson J: Properties of verapamil-hypertensive multidrug-resistant Chinese Hamster Ovary cells. Cancer Res 48 4477-4483, 1988.
38. Willigham MC, Richert ND, Cornwell MM, Tsuruo T, Hamada H, Gottesman MM, Pastan IH: Immunohistochemical localization of GP170 at the plasma membrane of multidrug -resistant human cells. J Histochem Cytochem 35.1451-1456, 1987
39. Yosnimura A, Kawazuzu Y, Sumizawa T, Ichikawa M, Ikeda SI, Uda T, Akiyama SI Cytoplasmic orientation of two-domain structure of the multidrug transporter, P-Glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264:16282-16291, 1989.
40. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump Proc Natl Acad Sci USA 91.8822-8826, 1994